As part of a new research study that began July 1, five Department of Veterans Affairs medical centers are working together to develop an Artificial Intelligence algorithm that can predict if a case of prostate cancer might spread to other parts of the body.<\/p>\n
Eventually expanding to 14 sites, the study will analyze data from more than 5,000 Veterans diagnosed with high-risk prostate cancer who have undergone initial treatment.<\/p>\n
The new method will use diagnostic images (like MRIs), high resolution scans of prostate biopsies, and social determinants of health \u2013 which are variables like income and geographic location \u2014 to detect patterns indicative of aggressive prostate cancer.\u00a0 This data is all routinely obtained during the initial diagnosis and evaluation of a prostate cancer patient, so there will be no extra medical visits for the patient and minimal cost increase for the facility to use the AI.<\/p>\n
\u201cOnly in the VA can a researcher combine extensive electronic medical records, high-performance computing, and precision oncology care to create an innovation like this AI program,\u201d said Assistant Under Secretary for Health for Discovery, Dr. Carolyn Clancy. \u201cNo one else has incorporated socioeconomic conditions into a predictive model for high-risk prostate cancer, but we\u2019ve seen multiple studies showing how they are a factor in Veterans\u2019 health.\u201d<\/p>\n Investigators in the Predicting Metastatic Progression of High Risk Localized Prostate Cancer study are leveraging existing resources \u2014 such as cloud storage, computing infrastructure, and databases \u2014 that are unique to VA\u2019s enterprise-wide programs.\u00a0 These programs include the Million Veteran Program and the Prostate Cancer Foundation-VA partnership, which was highlighted in the recent PACT Act<\/a> and the 2023 OMNIBUS Appropriations ACT<\/a>.<\/p>\n \u201cA digital repository for data will allow for development, testing, and validation of prognostic classifiers that could positively impact clinical management of Veterans with high-risk prostate cancer,\u201d said Dr. Matthew Rettig, chief of oncology and hematology at the Greater Los Angeles VA Medical Center, and co-principal investigator for the study<\/strong>. \u201cThe infrastructure developed by this research will serve as a valuable hub for future discovery and \u2026 serve as a roadmap to develop similar AI algorithms for other cancers, such as lung cancer, and even non-cancerous diseases that commonly affect our Veterans.\u201d<\/p>\n Prostate cancer is the second-most commonly diagnosed cancer among U.S. Veterans, making up 30% of new cancer diagnoses in the VA, and is the second leading cause of cancer-related mortality. About one in eight men will be diagnosed with prostate cancer at some point in their lifetime.\u00a0 For more information about the VA\u2019s efforts in the battle against Prostate Cancer, please visit the ORD Website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" As part of a new research study that began July 1, five Department of Veterans Affairs medical centers are working together to develop an Artificial Intelligence algorithm that can predict if a case of prostate cancer might spread to other parts of the body. Eventually expanding to 14 sites, the study will analyze data from […]<\/p>\n","protected":false},"author":8,"featured_media":17418,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[499,204,5,368,500,164],"tags":[],"class_list":["post-17416","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence","category-cancer","category-health","category-news-releases","category-prostate-cancer","category-research"],"_links":{"self":[{"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/posts\/17416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17416"}],"version-history":[{"count":3,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/posts\/17416\/revisions"}],"predecessor-version":[{"id":17425,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/posts\/17416\/revisions\/17425"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/media\/17418"}],"wp:attachment":[{"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
(Photo by Claudia Gutierrez.)<\/em><\/figcaption><\/figure>\n
![<\/a>Dr. Isla Garraway, Greater Los Angeles VA Medical Center (GLA) investigator, uses a stock photo on her workstation at GLA to demonstrate a prostate MRI.\u00a0 If the AI research is successful, predictive algorithms will be able to use routinely collected data like MRIs and biopsies to predict how aggressive a case of prostate cancer will be.(Photo by Claudia Gutierrez.)<\/em><\/figcaption><\/figure>\nInvestigators in the Predicting Metastatic Progression of High Risk Localized Prostate Cancer study are leveraging existing resources \u2014 such as cloud storage, computing infrastructure, and databases \u2014 that are unique to VA\u2019s enterprise-wide programs.\u00a0 These programs include the Million Veteran Program and the Prostate Cancer Foundation-VA partnership, which was highlighted in the recent PACT Act<\/a> and the 2023 OMNIBUS Appropriations ACT<\/a>.<\/p>\n\u201cA digital repository for data will allow for development, testing, and validation of prognostic classifiers that could positively impact clinical management of Veterans with high-risk prostate cancer,\u201d said Dr. Matthew Rettig, chief of oncology and hematology at the Greater Los Angeles VA Medical Center, and co-principal investigator for the study<\/strong>. \u201cThe infrastructure developed by this research will serve as a valuable hub for future discovery and \u2026 serve as a roadmap to develop similar AI algorithms for other cancers, such as lung cancer, and even non-cancerous diseases that commonly affect our Veterans.\u201d<\/p>\nProstate cancer is the second-most commonly diagnosed cancer among U.S. Veterans, making up 30% of new cancer diagnoses in the VA, and is the second leading cause of cancer-related mortality. About one in eight men will be diagnosed with prostate cancer at some point in their lifetime.\u00a0 For more information about the VA\u2019s efforts in the battle against Prostate Cancer, please visit the ORD Website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"As part of a new research study that began July 1, five Department of Veterans Affairs medical centers are working together to develop an Artificial Intelligence algorithm that can predict if a case of prostate cancer might spread to other parts of the body. Eventually expanding to 14 sites, the study will analyze data from […]<\/p>\n","protected":false},"author":8,"featured_media":17418,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[499,204,5,368,500,164],"tags":[],"class_list":["post-17416","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence","category-cancer","category-health","category-news-releases","category-prostate-cancer","category-research"],"_links":{"self":[{"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/posts\/17416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17416"}],"version-history":[{"count":3,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/posts\/17416\/revisions"}],"predecessor-version":[{"id":17425,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/posts\/17416\/revisions\/17425"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=\/wp\/v2\/media\/17418"}],"wp:attachment":[{"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adn.monetizemail.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}](\"https:\/\/adn.monetizemail.com\/wp-content\/uploads\/2023\/07\/Prostate-AI-2B-scaled-6.jpeg\"){kind=link}